T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy

被引：0
|
作者：
Arthur, Claire [1 ]
Teo, Mark [2 ]
机构：
[1] Christie NHS Fdn Trust, Dept Consultant Clin Oncologist, Wilmslow Rd, Manchester M20 4BX, England
[2] St James Univ Hosp, Leeds Canc Ctr, Dept Consultant Clin Oncologist, Leeds, England
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
ORGAN PRESERVATION; BOOST;
D O I：
10.1093/bjs/znad323
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [21] What is the optimal treatment in clinical stage T3N0M0 rectal cancer?
    Tural, Deniz
    Yildiz, Ozcan
    Elcin, Olgun
    Erdamar, Sibel
    Guney, Sabri
    Demireli, Fuat
    Buyukunal, Evin
    Serdengecti, Suheyla
    JOURNAL OF BUON, 2014, 19 (01): : 97 - 102
  • [22] The role of neoadjuvant chemoradiotherapy in locally advanced resectable gallbladder cancer (T3N0M0, T1-3N1M0)
    Anand, U.
    Chatterjee, T.
    Sahni, P.
    Pal, S.
    Dash, N. R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A147 - A147
  • [23] Prognostic Factor of Completely Resected and Pathologic T3 N0 M0 Thymic Epithelial Tumor
    Tang, En-Kuei
    Chang, Jia-Ming
    Chang, Chao-Chun
    Wu, Shang-Yin
    Huang, Wei-Li
    Chen, Ying-Yuan
    Kam, Hong-Hong
    Yen, Yi-Ting
    Tseng, Yau-Lin
    ANNALS OF THORACIC SURGERY, 2021, 111 (04): : 1164 - 1173
  • [24] Preoperative chemoradiotherapy for clinically diagnosed T3N0 rectal cancer
    Park, In Ja
    Kim, Jee Yeon
    Yu, Chang Sik
    Lee, Jong Seok
    Lim, Seok-Byung
    Lee, Jong Lyul
    Yoon, Yong Sik
    Kim, Chan Wook
    Kim, Jin Cheon
    SURGERY TODAY, 2016, 46 (01) : 90 - 96
  • [25] Preoperative chemoradiotherapy for clinically diagnosed T3N0 rectal cancer
    In Ja Park
    Jee Yeon Kim
    Chang Sik Yu
    Jong Seok Lee
    Seok-Byung Lim
    Jong Lyul Lee
    Yong Sik Yoon
    Chan Wook Kim
    Jin Cheon Kim
    Surgery Today, 2016, 46 : 90 - 96
  • [26] Long-term results of concurrent chemoradiotherapy followed by high dose rate brachytherapy for T2-3 N0-1 M0 esophageal carcinoma
    Yorozu A.
    Toya K.
    Dokiya T.
    Esophagus, 2006, 3 (1) : 1 - 5
  • [27] The nonsurgical management of early stage (T1/2 N0 M0) laryngeal cancer: A population analysis
    Lee, Kevin C.
    Chuang, Sung-Kiang
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2020, 130 (01): : 18 - 24
  • [28] EARLY ANDROGEN ABLATION FOR STAGE D1 (N1 TO N3, M0) PROSTATE-CANCER - PROGNOSTIC VARIABLES AND OUTCOME
    ZAGARS, GK
    SANDS, ME
    POLLACK, A
    VONESCHENBACH, AC
    JOURNAL OF UROLOGY, 1994, 151 (05): : 1330 - 1333
  • [29] Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer
    Curran, B
    Lenehan, K
    Mulcahy, H
    Tighe, O
    Bennett, MA
    Kay, EW
    O'Donoghue, DP
    Leader, M
    Croke, DT
    GUT, 2000, 46 (02) : 200 - 204
  • [30] PT1-T2 N0 M0 BREAST CANCER WITH EARLY RECCURENCE
    Zemni, I.
    Haddad, S.
    Adouni, O.
    Saadallah, F.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A62 - A63
12345